Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Colorectal Neoplasms × alectinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Hematologic Neoplasms 2 Solid Tumors 1 Sexual Dysfunction, Physiological 1 Rare Tumor 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Eunuchism 1 Erectile Dysfunction 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Bevacizumab 59 Cetuximab 41 Fluorouracil 39 pembrolizumab 30 Oxaliplatin 30 Leucovorin 27 Irinotecan 24 Folfox protocol 20 Specimen Handling 18 HMPL-013 17 Capecitabine 17 Blood Specimen Collection 16 trifluridine tipiracil drug combination 13 Magnetic Resonance Spectroscopy 13 Biopsy 11 regorafenib 10 Trifluridine 10 Panitumumab 10 Gemcitabine 10 Carboplatin 10 Nivolumab 9 IFL protocol 9 Drug Therapy 9 Cisplatin 9 encorafenib 8 Standard of Care 8 Interviews as Topic 8 sintilimab 7 Radiosurgery 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05725200 2023-02-21

EVIDENT

Oslo University Hospital

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡